docetaxel anhydrous has been researched along with Hypopharyngeal Cancer in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.33) | 18.2507 |
| 2000's | 8 (26.67) | 29.6817 |
| 2010's | 18 (60.00) | 24.3611 |
| 2020's | 3 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, H; Grénman, R; Kawabata-Iwakawa, R; Kawata-Shimamura, Y; Nakahira, M; Nishiyama, M; Okazaki, Y; Sugasawa, M; Yoda, T | 1 |
| Baste, N; Berrocal-Jaime, A; Cruz-Hernández, JJ; Cunquero-Tomas, AJ; Del Barco-Morillo, E; García-Girón, C; Grau, JJ; Guix, M; Hitt, R; Iglesias, L; Lambea-Sorrosal, J; León-Vintró, X; López-Pousa, A; Martínez-Trufero, J; Ocaña, A | 1 |
| Li, M; Li, Y; Tong, X; Yang, G | 1 |
| Bockmühl, U; Boehm, A; Budach, V; Bünzel, J; de Wit, M; Dietz, A; Eich, HT; Esser, D; Feyer, P; Flentje, M; Foerg, T; Görner, M; Guntinas-Lichius, O; Hagen, R; Hautmann, MG; Held, S; Jungehülsing, M; Keilholz, U; Klussmann, JP; Knödler, M; Kölbl, O; Kuhnt, T; Lenarz, T; Lordick, F; Maschmeyer, G; Münter, M; Pfreundner, L; Preyer, S; Remmert, S; Rudack, C; Scheich, M; Schilling, V; Schreiber, F; Schroeder, U; Sittel, C; Strutz, J; Sudhoff, H; Thurnher, D; Vogel, K; Welkoborsky, HJ; Westhofen, M; Wichmann, G; Wiegand, S; Wollenberg, B | 1 |
| Chen, L; Huang, JQ; Li, J; Sun, W; Wen, WP; Wen, YH; Zhu, XL | 1 |
| Daiko, H; Ebihara, M; Fujii, S; Hayashi, R; Miyazaki, M; Sakuraba, M; Shinozaki, T; Suzuki, K; Tahara, M; Zenda, S | 1 |
| Chung, IJ; Joo, YE; Kim, SA; Lee, DH; Lee, JK; Lee, KH; Lim, SC; Park, YL; Yoon, TM | 1 |
| Inohara, H; Isohashi, F; Nakahara, S; Ogawa, K; Seo, Y; Sumida, I; Suzuki, O; Takenaka, Y; Tomiyama, Y; Yamamoto, Y; Yoshii, T; Yoshioka, Y | 1 |
| Benezery, K; Bozec, A; Chamorey, E; Chand, ME; Dassonville, O; Demard, F; Ettaiche, M; Falewee, MN; Hannoun-Lévi, JM; Haudebourg, J; Hebert, C; Leysalle, A; Peyrade, F; Poissonnet, G; Riss, JC; Saada, E; Santini, J; Sudaka, A; Vandersteen, C | 1 |
| Ikeda, M; Imaizumi, M; Matsui, T; Matsuzuka, T; Nakaegawa, Y; Nomoto, M; Nomoto, Y; Omori, K; Saijoh, S; Sato, H; Suzuki, M; Suzuki, R; Suzuki, Y; Tada, Y; Tani, A | 1 |
| Ando, M; Asakage, T; Omura, G; Saito, Y; Yamasoba, T; Yoshida, M | 1 |
| Alfonsi, M; Calais, G; Chapet, S; Garaud, P; Jadaud, E; Janoray, G; Pointreau, Y; Sire, C | 1 |
| Baba, F; Miyakawa, A; Murai, T; Nagai, A; Ogino, H; Shibamoto, Y; Sugie, C; Yanagi, T | 1 |
| Alfieri, S; Bergamini, C; Bossi, P; Cavallo, A; Cova, A; Granata, R; Huber, V; Iacovelli, NA; Imbimbo, M; Licitra, L; Locati, L; Mariani, L; Miceli, R; Orlandi, E; Resteghini, C; Rivoltini, L | 1 |
| Asai, K; Kogo, R; Nakagawa, T; Nakashima, T; Uryu, H; Yasumatsu, R | 1 |
| Aizawa, T; Ishibashi, N; Maebayashi, T; Saito, T; Sakaguchi, M | 1 |
| Adkins, DR; Blajman, CR; Cohen, RB; Cullen, KJ; Frenette, GP; Freue, JM; Gorbunova, VA; Haddad, RI; Mickiewicz, EA; Norris, CM; Plinar, LF; Posner, MR; Raez, LE; Roessner, MR; Shin, DM; Steinbrenner, LM; Tishler, RB; Tjulandin, SA; Winquist, EW; Wirth, LJ | 1 |
| Alfonsi, M; Calais, G; Chapet, S; Faivre, S; Garaud, P; Guerrif, S; Pointreau, Y; Sire, C; Tortochaux, J; Tuchais, C | 1 |
| Fujii, M; Fukada, J; Kawaguchi, O; Kubo, A; Kunieda, E; Ohashi, T; Shigematsu, N; Shiotani, A; Takeda, A; Tomita, T | 1 |
| Arai, H; Kobayashi, Y; Maruyama, H; Matsuda, A; Matsushita, A; Matsutani, T; Miyamoto, M; Nishi, Y; Sasajima, K; Sugiura, A; Suzuki, S; Tajiri, T; Wakabayashi, H; Yanagi, K; Yokoyama, T | 1 |
| Fietkau, R; Iro, H; Klautke, G; Kuwert, T; Lell, M; Linke, R; Semrau, S; Uder, M; Waldfahrer, F | 1 |
| Debus, J; Desta, A; Habl, G; Jensen, AD; Krauss, J; Mavtratzas, A; Münter, MW; Potthoff, K; Windemuth-Kiesselbach, C | 1 |
| Blenc, AM; Boxwala, I; Chisti, MM; Jaiyesimi, I; Micale, MA; Muslimani, A | 1 |
| Furusaka, T; Ikeda, M; Matsuda, A; Matsuda, H; Tanaka, A | 1 |
| Kawabori, S; Taniguchi, M; Watanabe, A | 1 |
| Miyahara, H; Naito, K; Yane, K | 1 |
| Kajikawa, H; Matsushiro, N; Miyahara, H; Nario, K; Sasai, H | 1 |
| Abe, K; Hiramatsu, H; Itoh, H; Nakamura, K; Okamoto, I; Shimizu, S; Suzuki, M; Takada, D; Tokashiki, R; Tsukahara, K; Yoshida, T | 1 |
| Colpaert, C; Schrijvers, D; Van den Brande, J; Vermorken, JB | 1 |
| Aihara, T; Akisada, T; Fukuda, K; Gyoten, M; Harada, T; Hiratsuka, J; Imai, S; Imajo, Y; Kajihara, Y; Morita, N; Takemoto, T | 1 |
8 trial(s) available for docetaxel anhydrous and Hypopharyngeal Cancer
| Article | Year |
|---|---|
Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Organ Sparing Treatments; Prognosis; Radiotherapy; Salvage Therapy; Survival Rate | 2018 |
Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; DNA, Viral; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Laryngeal Neoplasms; Male; Middle Aged; Organ Sparing Treatments; Oropharyngeal Neoplasms; Papillomaviridae; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Stomatitis; Survival Rate; Taxoids | 2015 |
Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Kaplan-Meier Estimate; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoplasm Staging; Organ Sparing Treatments; Squamous Cell Carcinoma of Head and Neck; Taxoids; Time Factors; Treatment Outcome | 2016 |
Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Laryngectomy; Male; Middle Aged; Organ Sparing Treatments; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome | 2017 |
Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Proportional Hazards Models; Radiotherapy, Adjuvant; Risk Assessment; Taxoids; Time Factors; Treatment Outcome | 2009 |
Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Karnofsky Performance Status; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neoadjuvant Therapy; Radiotherapy, Adjuvant; Remission Induction; Taxoids; Treatment Outcome; Young Adult | 2009 |
Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-C-HIT.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carbon; Cetuximab; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Genetic Testing; Humans; Hypopharyngeal Neoplasms; Ions; Laryngeal Neoplasms; Oropharyngeal Neoplasms; Radioimmunotherapy; Taxoids | 2011 |
A phase I-II study of bi-weekly docetaxel combined with radiation therapy for patients with cancer of the larynx/hypopharynx.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Humans; Hypopharyngeal Neoplasms; Injections, Intravenous; Laryngeal Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Taxoids; Treatment Outcome | 2007 |
22 other study(ies) available for docetaxel anhydrous and Hypopharyngeal Cancer
| Article | Year |
|---|---|
Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents.
Topics: Cell Adhesion Molecules, Neuronal; Cisplatin; Docetaxel; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Mucoproteins; Oncogene Proteins; Precision Medicine | 2022 |
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase III as Topic; Confidence Intervals; Docetaxel; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Intention to Treat Analysis; Laryngeal Neoplasms; Mouth Neoplasms; Progression-Free Survival; Randomized Controlled Trials as Topic; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome; Tumor Burden | 2021 |
Nursing Observation on the Clinical Efficacy and Toxicity of Lobaplatin Compared with Cisplatin in the Treatment of Locally Advanced Hypopharyngeal Carcinoma Based on Intelligent CT Imaging.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclobutanes; Docetaxel; Humans; Hypopharyngeal Neoplasms; Neoplasm Staging; Organoplatinum Compounds; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Dynamic changes in chemosensitivity immune predictors in patients with hypopharyngeal cancer treated with induction chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cisplatin; Docetaxel; Female; Flow Cytometry; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Male; Middle Aged; Prospective Studies; T-Lymphocytes, Regulatory | 2019 |
The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Docetaxel; Dose Fractionation, Radiation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome | 2013 |
EGR1 regulates radiation-induced apoptosis in head and neck squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Squamous Cell; Cell Line, Tumor; Chemoradiotherapy; Cisplatin; Docetaxel; Early Growth Response Protein 1; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, Immediate-Early; Humans; Hypopharyngeal Neoplasms; Kaplan-Meier Estimate; Laryngeal Neoplasms; Larynx; Male; Middle Aged; Neoplasm Proteins; Organ Sparing Treatments; Photons; Radiation Tolerance; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Taxoids; Transfection | 2015 |
Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Enteral Nutrition; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Intubation, Gastrointestinal; Male; Middle Aged; Nutritional Status; Organ Sparing Treatments; Retrospective Studies; Taxoids | 2016 |
Chemoselection combined with alternating chemoradiotherapy or surgery for hypopharyngeal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Protocols; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Pharyngectomy; Taxoids; Treatment Outcome | 2016 |
[Retrospective Study of Laryngeal Preservation Treatment for Hypopharyngeal Carcinoma with Transoral Resection or Induction Chemotherapy].
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Docetaxel; Female; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Larynx; Male; Middle Aged; Retrospective Studies; Taxoids | 2015 |
Definitive Radiotherapy Following Induction Chemotherapy for Hypopharyngeal Cancer: Selecting Candidates for Organ-Preserving Treatment Based on the Response to Induction Chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Patient Selection; Proportional Hazards Models; Risk Factors; Taxoids; Time Factors; Treatment Outcome | 2016 |
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cytokines; Docetaxel; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Interleukin-1beta; Interleukin-6; Laryngeal Neoplasms; Mouth Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy, Intensity-Modulated; Saliva; Severity of Illness Index; Stomatitis; Taxoids; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
Clinical Outcomes of Hypopharyngeal Cancer Receiving Definitive Radiotherapy with Concurrent Chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deglutition Disorders; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mucositis; Multivariate Analysis; Neoplasm Staging; Neoplasms, Second Primary; Neutropenia; Radiotherapy Dosage; Retrospective Studies; Taxoids; Treatment Outcome | 2017 |
Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cause of Death; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Male; Middle Aged; Mucositis; Neoadjuvant Therapy; Neoplasm Staging; Oropharyngeal Neoplasms; Radiotherapy Dosage; Retrospective Studies; Taxoids | 2010 |
[A case of double advanced cancer with esophageal and hypopharyngeal carcinoma responding completely to combination chemotherapy of docetaxel/5-fluorouracil and nedaplatin with radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Esophageal Neoplasms; Esophagoscopy; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Male; Neoplasm Staging; Neoplasms, Multiple Primary; Organoplatinum Compounds; Remission Induction; Taxoids; Tomography, X-Ray Computed | 2009 |
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early r
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Laryngeal Neoplasms; Leukopenia; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Opportunistic Infections; Paclitaxel; Positron-Emission Tomography; Radiodermatitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Salvage Therapy; Taxoids; Thrombocytopenia; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 2011 |
Langerhans/dendritic cell sarcoma arising from hairy cell leukemia: a rare phenomenon.
Topics: Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cell Transdifferentiation; Chromosome Aberrations; Deoxycytidine; Disease Progression; Docetaxel; Female; Gemcitabine; Gene Rearrangement, B-Lymphocyte; Humans; Hypopharyngeal Neoplasms; Immunophenotyping; Karyotyping; Langerhans Cell Sarcoma; Leukemia, Hairy Cell; Mutation; Neoplastic Stem Cells; Pyriform Sinus; Taxoids | 2012 |
Laryngeal preservation in advanced piriform sinus squamous cell carcinomas using superselective intra-arterial chemoradiation therapy with three agents.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Infusions, Intra-Arterial; Larynx; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Organ Sparing Treatments; Pyriform Sinus; Survival Rate; Taxoids | 2013 |
[A case of hypopharyngeal carcinoma in which a complete response to chemotherapy was achieved with docetaxel, cisplatin, 5-FU and levofolinate].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Leucovorin; Male; Paclitaxel; Remission Induction; Taxoids | 2002 |
[A case of posterior wall cancer of the hypopharynx treated with docetaxel followed by radiation].
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Female; Humans; Hypopharyngeal Neoplasms; Paclitaxel; Taxoids | 2003 |
[Four cases of hypopharyngeal cancer treated with docetaxel, cisplatin, and 5-FU followed by radiotherapy and/or neck dissection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Leukopenia; Male; Middle Aged; Neck Dissection; Neoadjuvant Therapy; Prognosis; Radiotherapy Dosage; Taxoids | 2004 |
Cytomegalovirus colitis after administration of docetaxel-5-fluorouracil-cisplatin chemotherapy for locally advanced hypopharyngeal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Colitis; Cytomegalovirus Infections; Docetaxel; Fatal Outcome; Fluorouracil; Ganciclovir; Humans; Hypopharyngeal Neoplasms; Immune Tolerance; Male; Middle Aged; Paclitaxel; Taxoids | 1999 |
[A case of advanced hypopharyngeal carcinoma successfully treated with superselective intra-arterial infusion of docetaxel].
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Fluorouracil; Humans; Hypopharyngeal Neoplasms; Infusions, Intra-Arterial; Male; Paclitaxel; Taxoids | 2002 |